XBI News and Press, SPDR Series Trust S&P Biotech From 05/09/24

2024-05-09 14:14:37 ET More on iShares Biotechnology ETF: Catch The Medical Breakthroughs With The IBB ETF IBB: Let It Rest Healthcare dealmakers see increased M&A, valuations in 2024: KPMG Top 10 ETFs have the lowest weighted average free cash flow yield...

2024-05-09 08:59:08 ET More on Editas Medicine Editas Medicine, Inc. (EDIT) Q1 2024 Earnings Call Transcript Editas Medicine, Inc. (EDIT) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript) Editas Medicine, Inc. (EDIT) Leerink Partners Global B...

2024-05-07 22:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-03 07:40:00 ET Summary Following last year's strong close, first quarter returns for the capital markets were driven by hope and a measure of fear. The bond market did not fare as well, beginning first with the Fed urging caution about the timing and magnitude of rate cuts...

2024-05-01 17:47:07 ET Summary Leveraged ETFs have a path-dependent drift: here is a dashboard with 22 of them. Leveraged ETFs in semiconductors, biotechnology and silver show the largest drifts. The Direxion Daily S&P 500® Bull 2X Shares ETF has suffered from decay r...

2024-04-30 15:03:39 ET Summary The biotech sector has experienced significant volatility but has returned around the same as the risk-free return from the 10-Year Treasury over the past year. There are two key items that will determine the direction of small and midcap biotech sto...

2024-04-25 10:05:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP returned 6.0% for the First Quarter of 2024. The Fund has annualized returns of 10.0% since inception, compa...

2024-04-23 13:12:48 ET Summary The recent lack of M&A activity and rising interest rates have helped trigger an approximate 20% decline in small-cap biotech equities. Drug blockbusters facing key patent expirations and Big Pharma's surplus of cash suggest increased M&A vol...

2024-04-21 10:49:18 ET Summary The yield on the 10-Year Treasury has risen to 4.62% from under 3.9% in late February. Rising rates are taking an increasing toll on the market, as the S&P 500 posted its worst weekly performance since March of 2023 this week. Bubbles in the ...

2024-04-19 11:29:12 ET Summary SPDR S&P Biotech ETF offers a buying opportunity after a recent decline and trades close to the 200-day moving average. XBI has a strong long-term track record, providing generous total returns for shareholders. The biotech sector is seeing i...